DEUTSCHE BANK AG\ - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 172 filers reported holding ANTARES PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$632,000
-44.9%
154,063
-52.1%
0.00%
-100.0%
Q4 2021$1,147,000
-33.2%
321,489
-31.8%
0.00%0.0%
Q3 2021$1,717,000
-44.4%
471,419
-33.4%
0.00%0.0%
Q2 2021$3,086,000
+41.2%
707,716
+33.1%
0.00%0.0%
Q1 2021$2,186,000
+208.3%
531,689
+199.3%
0.00%
Q4 2020$709,000
+28.7%
177,629
-13.0%
0.00%
Q3 2020$551,000
+14.3%
204,081
+16.6%
0.00%
Q2 2020$482,000
-22.6%
175,021
-33.7%
0.00%
-100.0%
Q1 2020$623,000
-83.5%
263,923
-67.3%
0.00%
-50.0%
Q4 2019$3,787,000
+1224.1%
806,141
+832.5%
0.00%
Q3 2019$286,000
-74.6%
86,446
-74.8%
0.00%
-100.0%
Q2 2019$1,126,000
-63.8%
342,828
-66.6%
0.00%
-50.0%
Q1 2019$3,111,000
+513.6%
1,027,481
+449.9%
0.00%
Q4 2018$507,000
-75.6%
186,851
-69.8%
0.00%
-100.0%
Q3 2018$2,075,000
+59.2%
618,173
+22.3%
0.00%
Q2 2018$1,303,000
+217.8%
505,551
+170.6%
0.00%
Q1 2018$410,000
-35.4%
186,839
-41.6%
0.00%
Q4 2017$635,000
-73.5%
319,943
-56.7%
0.00%
-100.0%
Q3 2017$2,395,000
-25.9%
739,608
-26.4%
0.00%0.0%
Q2 2017$3,233,000
+722.6%
1,004,627
+625.6%
0.00%
Q1 2017$393,000
+62.4%
138,459
-40.0%
0.00%
Q2 2016$242,000
+65.8%
230,825
+36.6%
0.00%
Q1 2016$146,000
-36.8%
168,977
-12.1%
0.00%
Q4 2015$231,000
+42.6%
192,346
+100.8%
0.00%
Q3 2015$162,000
-10.5%
95,766
+9.8%
0.00%
Q2 2015$181,000
+34.1%
87,185
+74.3%
0.00%
Q1 2015$135,000
-38.4%
50,023
-41.4%
0.00%
Q4 2014$219,000
+14.1%
85,432
-19.7%
0.00%
Q3 2014$192,000
+1.1%
106,337
+48.4%
0.00%
Q2 2014$190,000
-34.9%
71,642
-14.4%
0.00%
Q1 2014$292,000
+24.8%
83,717
+59.6%
0.00%
Q4 2013$234,000
-65.4%
52,462
-68.6%
0.00%
Q3 2013$677,000166,9020.00%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders